TY  - JOUR
AU  - Hermans, Lucas Etienne
AU  - Svicher, Valentina
AU  - Pas, Suzan Diepstraten
AU  - Salpini, Romina
AU  - Alvarez, Marta
AU  - Ben Ari, Ziv
AU  - Boland, Greet
AU  - Bruzzone, Bianca
AU  - Coppola, Nicola
AU  - Seguin-Devaux, Carole
AU  - Dyda, Tomasz
AU  - Garcia, Federico
AU  - Kaiser, Rolf
AU  - Köse, Sukran
AU  - Krarup, Henrik
AU  - Lazarevic, Ivana
AU  - Lunar, Maja M
AU  - Maylin, Sarah
AU  - Micheli, Valeria
AU  - Mor, Orna
AU  - Paraschiv, Simona
AU  - Paraskevis, Dimitrios
AU  - Poljak, Mario
AU  - Puchhammer-Stöckl, Elisabeth
AU  - Simon, François
AU  - Stanojevic, Maja
AU  - Stene-Johansen, Kathrine
AU  - Tihic, Nijaz
AU  - Trimoulet, Pascale
AU  - Verheyen, Jens
AU  - Vince, Adriana
AU  - Weis, Nina
AU  - Yalcinkaya, Tülay
AU  - Lepej, Snjezana Zidovec
AU  - Perno, Carlo
AU  - Boucher, Charles A B
AU  - Wensing, Annemarie M J
PY  - 2015
DO  - 10.1093/infdis/jiv363
UR  - http://hdl.handle.net/10668/9939
T2  - The Journal of infectious diseases
AB  - European guidelines recommend treatment of chronic hepatitis B virus infection (CHB) with the nucleos(t)ide analogs (NAs) entecavir or tenofovir. However, many European CHB patients have been exposed to other NAs, which are associated with therapy...
LA  - en
KW  - antiviral drug resistance
KW  - genotypic resistance testing
KW  - hepatitis B virus
KW  - nucleos(t)ide analogs
KW  - Adult
KW  - Antiviral Agents
KW  - Cross-Sectional Studies
KW  - Drug Resistance, Viral
KW  - Female
KW  - Genotype
KW  - Hepatitis B virus
KW  - Hepatitis B, Chronic
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prevalence
TI  - Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).
TY  - research article
VL  - 213
ER  -